SS Innovations

Pioneering a Visionary Future

for Medical Robotics

About Us

Bringing Tomorrow's

Technologies Today

 
SS Innovations has been involved in the field of medical robotic technology over the past decade.  Founder and CEO, Dr. Sudhir Srivastava, has made it his personal mission to find ways to improve gold standard surgical procedures through the union of great skill, patient care and continually advancing technologies.  By pushing the limits of technology, SS Innovations aims to improve the quality of medical services for patients all over the world.

 

From developed to developing nations, it is the goal of SS Innovations to make available the latest technologies to a global population that can most benefit from our advancements in medical engineering.  This is the guiding philosophy at SS Innovations.  We approach our research, development and utility in the field of medicine with the idea that ultimately our efforts will result in all patients, across the world, benefitting from our technologies.

Unparalleled Technology

the possibilities are endless

Technology is at the core of all that we do at SS Innovations. We are the visionaries of tomorrow and our primary goal is to be able to integrate intelligent ways of utilising technology that will inevitably help build a better future for our patients.  With our esteemed and world renown medical leadership and core team of engineers, we strive to bring the latest advancements into the field of surgical medicine. Through these applications, it is our goal to produce a superior robotic assisted surgical system, which is both, financially attainable and conveniently accessible to all of our patients around the globe.

 
 

OUR BOARD of DIRECTORS

Sudhir Srivastava, MD
Chairman & CEO
Sudheer Kuppam
Valluvan Jeevandandam, MD
Tim Adams

Dr. Sudhir Srivastava is one of the foremost global experts in robotic cardiac surgery.  Until date, he has performed the largest number of robotic cardiac procedures in the entire world.  Dr. Srivastava, along with ten additional physicians, founded AllianceHospital LTD, a center of excellence in the treatment of cardiovascular disease, in Odessa, Texas in July 2003 and served as its chairman for four years. While there, he performed the world’s first single vessel beating heart TECAB in the United States. He also proceeded to perform two world’s first double and triple vessel TECAB on a beating heart and is the only person in the world to have perfomed a quadruple vessel beating heart TECAB. He has made it his mission to make available his skill to all those with the desire to learn these minimally invasive techniques. Dr. Srivastava has trained hundreds of teams around the world and is constantly trying to find ways to improve the field of robotic assisted surgery.  Alongside his tireless efforts and determination, Dr. Srivastava continues to push the envelope of surgical science as we know it today.

Mr. Sudheer Kumar Kuppam is the Founder and Managing Partner at Epsilon Venture Partners. He serves as a Co-Founder at Zebi Data India Pvt. Ltd. Mr. Kuppam was a Managing Director of Asia Pacific at Intel Capital till August 2016. Mr. Kuppam joined Intel Capital in 2000. He oversees investments in Asia Pacific region with a focus on India, Japan, Australia, and South East Asia. At the firm, Mr. Kuppam is responsible for leading Intel Capital's investment strategies and expansion plans. He was working as a Director of Intel Capital's Flash Memory and Semiconductor Sector. Prior to that, Mr. Kuppam was an Engineering Manager, managing a $100 million operational area in Intel's Technology and Manufacturing Group. Previously, he was a Process Development Engineer at LSI Logic. Mr. Kuppam is a Board Observer of Real Image Media Technologies Pvt. Ltd. and Tejas Networks India Pvt. Ltd. He served as a Director of Vignani Technologies Pvt. Ltd. His general interest includes Asia Pacific investments. Mr. Kuppam holds a Bachelors degree from the Indian Institute of Technology, Madras and a Masters degree from Rensselaer Polytechnic Institute, United States.

Dr. Valluvan Jeevanandam specializes in the surgical management of heart failure, and is an expert in high-risk cardiac surgery. He has performed more than 1,000 heart transplants -- including the total artificial heart -- and countless cardiac surgery procedures, including transmyocardial laser revascularization, complex valve reconstruction, and minimally invasive coronary artery bypass graft surgery.  Dr. Jeevanandam is a pioneer in the field of mechanical circulatory assist devices. In October 2000, he was the first surgeon in the world to successfully implant the CardioVad, a revolutionary, permanent circulatory assist device that boosts heart function in patients with severe heart failure who are not candidates for transplant. He continues to be a recognized leader in the field of advanced heart failure and currently serves on the FDA Device Panel.  He is a world-renowned surgeon, having started high risk and cardiac assist programs in countries including China, India, the Middle East and South America.

Tim P. Adams, FACHE currently serves as CEO of Tenet’s Texas Region consisting of 22 acute care facilities in Texas with annual net operating revenues in excess of $4 billion.  In this role his primary responsibilities included strategic planning, market development, network development, quality improvement, and overall operational and financial performance of the region.  Tim has over 30 years of healthcare experience.  Prior to joining Tenet, he served as Division Vice President with Community Health Systems (CHS) and CEO of their hospital in Austin, TX.  In his division role he was responsible for the operational and financial performance of CHS’s 18 Texas hospitals with operating net revenues in excess of $1.6 billion. Tim is board-certified in healthcare management and a Fellow with the American College of Healthcare Executives (FACHE). He received his BA degree from Baylor University and holds a Master’s degree in business administration from the University of Texas in El Paso.  Tim serves on THA board of directors as well as several state and national boards.  

Mr Shum has over 30 years of experience in Medical device industry and was recognized as “The leader of Shanghai Medical Device Industry”. He is the CEO and chairman of HealForce Group.  Established in 1989, Heal Force Bio-Meditech Holdings Limited is a Chinese manufacturer of medical equipment, laboratory equipment, and healthcare equipment. With over two decades of experience in the field, Heal Force is able to provide a vast range of products, including our electrosurgical generator, anesthetic machine, patient monitor, biological safety cabinet, laboratory centrifuge, pulse oximeter, massager, and more. In addition, we can also offer customized solutions for clients' special requirements.  Headquartered in Hong Kong, Heal Force has grown steadily and now has many subsidiaries, like Heal Force Development Limited, Nison Instrument (Shanghai) Limited, Shanghai Lishen Scientific Equipment Company, Shenzhen Creative Industry Company, Shanghai Lonyee Company, to name a few. 

Shum Yam Wa

OUR SENIOR MANAGEMENT

Vishwa Srivastava
President, OMNI 3DHD
Supervisor, SSI

Vishwa Srivastava has been involved in the field of robotic assisted surgery since 2008.  He completed his premedical courses at Columbia University in New York City and is presently in the process of completing his medical degree.  In 2009,  under the guidance of Dr. Sudhir Srivastava, he was the first person in the field to develop a high definition teaching website that would assist in cardiothoracic surgeons lessening their respective learning curves through didactic training modules as they transitioned from conventional approaches to minimally invasive robotic approaches.  Soon after, he began his research in the concept of tele mentoring in surgical procedures.  In 2011, while working as the VP of Marketing and Technology at the International Centre for Robotic Surgery with Dr. Srivastava in New Delhi, Vishwa led the development of the OMNI 3D Medical Visualization system.  The clinical trials for the OMNI system were conducted at Shanghai Ruijin Hospital, Medanta Hospital in New Delhi, the University of Chicago, Temple University in Philadelphia and Lennox Hill Hospital in New York City. Vishwa presently serves as the President of OMNI 3D HD and is advancing the existing platform for availability in the global marketplace.

Mr. Walter A. Aviles, Walt has been Chief Technical Officer of Novint Technologies Inc. since 2001. Mr. Aviles has over 20 years of technical and managerial experience in commercial, government and academic environments in the design and development of advanced, first of a kind, human/machine interfaces, virtual environments and robotic systems. As a Founding Principal of Teneo Computing, Inc., he worked on projects including: a prototype dental cavity preparation simulator developed in collaboration with the Harvard University School of Dentistry; a three-dimensional data understanding and editing system for volumetric seismic data developed with Mobil Oil; and a computer interface for the blind research system developed with NHK Television of Japan. Prior to founding Teneo Computing, from 1996 to 1999, Mr. Aviles served as a Vice President of Product Development at SensAble Technologies in Cambridge, Massachusetts, where he helped establish its software group and developed the world's first commercial haptics software toolkit. He also spearheaded the development of real-time techniques and commercial applications for interaction with volumetric models including the FreeForm application. He is a Founding Member of the Virtual Environment and Teleoperator Research Consortium (VETREC), an Associate Editor of the MIT Press journal Presence and a Member of the Tau Beta Pi and Sigma Chi engineering honor associations. He holds undergraduate and graduate degrees in Electrical Engineering and Computer Science from Stanford University and The Massachusetts Institute of Technology.

Walter Aviles
Chief Technology Officer

    CONTACT

SS Innovations

OUR ADDRESS

Suite 1012, 10th Floor, Building 5, Leo Block, Singapore Hangzhou Science & Technology Park Road HEDA

Hangzhou 310018, China

info@ssinnovations.org

 

For any general inquiries, please fill in the following contact form:

 

OUR LEADERSHIP

SSI BOARD of DIRECTORS

Sudhir Srivastava, MD
Chairman & CEO

Dr. Sudhir Srivastava is one of the foremost global experts in robotic cardiac surgery. Until date, he has performed the largest number of robotic cardiac procedures in the entire world.  Dr. Srivastava, along with ten additional physicians, founded Alliance Hospital LTD, a center of excellence in the treatment of cardiovascular disease, in Odessa, Texas in July 2003 and served as its chairman for four years. While there, he performed the world’s first single vessel beating heart TECAB in the United States. He also proceeded to perform two world’s first double and triple vessel TECAB on a beating heart and is the only person in the world to have perfomed a quadruple vessel beating heart TECAB while at the University of Chicago.   Dr. Srivastava is an active member of the Society of Thoracic Surgeons, AATS, the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) and is a founder of the Robotic Revascularization Society.  Dr. Srivastava has made it his mission to make available his skill to all those with the desire to learn these minimally invasive techniques. Dr. Srivastava has trained hundreds of teams around the world and is constantly trying to find ways to improve the field of robotic assisted surgery.  Alongside his tireless efforts and determination, Dr. Srivastava continues to push the envelope of surgical science as we know it today.

Dr. Valluvan Jeevanandam specializes in the surgical management of heart failure, and is an expert in high-risk cardiac surgery. He has performed more than 1,000 heart transplants -- including the total artificial heart -- and countless cardiac surgery procedures, including transmyocardial laser revascularization, complex valve reconstruction, and minimally invasive coronary artery bypass graft surgery.  Dr. Jeevanandam is a pioneer in the field of mechanical circulatory assist devices. In October 2000, he was the first surgeon in the world to successfully implant the CardioVad, a revolutionary, permanent circulatory assist device that boosts heart function in patients with severe heart failure who are not candidates for transplant. He continues to be a recognized leader in the field of advanced heart failure and currently serves on the FDA Device Panel.  He is a world-renowned surgeon, having started high risk and cardiac assist programs in countries including China, India, the Middle East and South America.

Valluvan Jeevanandam, MD
Tim Adams

Tim P. Adams, FACHE currently serves as CEO of Tenet’s Texas Region consisting of 22 acute care facilities in Texas with annual net operating revenues in excess of $4 billion.  In this role his primary responsibilities included strategic planning, market development, network development, quality improvement, and overall operational and financial performance of the region.  Tim has over 30 years of healthcare experience.  Prior to joining Tenet, he served as Division Vice President with Community Health Systems (CHS) and CEO of their hospital in Austin, TX.  In his division role he was responsible for the operational and financial performance of CHS’s 18 Texas hospitals with operating net revenues in excess of $1.6 billion. Tim is board-certified in healthcare management and a Fellow with the American College of Healthcare Executives (FACHE). He received his BA degree from Baylor University and holds a Master’s degree in business administration from the University of Texas in El Paso.  Tim serves on THA board of directors as well as several state and national boards.  

SSI CARDIAC SURGERY ADVISORY BOARD

Husam Balkhy, MD
Chairman
University of ​​Chicago

Husam H. Balkhy, MD, is a pioneer in the field of minimally invasive and robotic cardiac surgery. He specializes in the treatment of coronary artery disease, heart valve disorders, atrial fibrillation and other cardiac diseases, using robotic and less invasive techniques in order to reduce pain, disability, and recovery time. Through education, he empowers his patients to take an active and informed role in their care. Dr. Balkhy is one of only a handful of surgeons in the world with extensive experience in performing robotic totally endoscopic beating heart coronary bypass grafting (TECAB). He also has a large experience with robotic mitral valve surgery, and robotic atrial fibrillation surgery as well as minimally invasive (port access) aortic valve surgery.  Dr. Balkhy has served as the primary investigator on several innovative studies designed to improve robotic assisted cardiac surgery. He has contributed to the development of coronary anastomotic connectors, and has the world's largest experience in the use of these devices that eliminate the need for large incisions and sutures during coronary surgery. He actively trains other physicians on how to use these devices.

Didier Loulmet, MD
New York University

Dr. Didier Loulmet is a pioneer in cardiac surgery specializing in closed-chest mitral valve repair, coronary bypass, cardiac tumor removal, and robotic surgery at NYU Langone’s Heart Valve Center and Robotic Surgery Center.  During his training, he spent several years at Hospital Broussais in Paris under the direction of Dr. Alain Carpentier, the inventor of tissue valve prostheses and mitral valve repair techniques. Dr. Loulmet was there until 2000, during the time when robotic cardiac surgery was pioneered.  He performed the world’s first robotic mitral valve repair with Dr. Carpentier in Paris in May 1998 and the world's first closed-chest robotic coronary artery bypass grafting in June 1998. Since then, he has performed thousands of mitral valve repair procedures, using the conventional approach, the less invasive technique, or robotic surgery.  Dr. Loulmet is recognized by New York Magazine in its listing of "The 100 Top Minimally Invasive Surgeons" and the "Best Doctors in New York."  He has also been named in Castle Connolly’s "America's Top Doctors" series for the last 15 years.  He is a member of many national and international professional societies, including The Society of Thoracic Surgeons, the European Association for Cardio-Thoracic Surgery, the International Society for Minimally Invasive Cardiothoracic Surgery, and the Heart Valve Society.

Valluvan Jeevanandam, MD
University of Chicago

Dr. Valluvan Jeevanandam specializes in the surgical management of heart failure, and is an expert in high-risk cardiac surgery. He has performed more than 1,000 heart transplants -- including the total artificial heart -- and countless cardiac surgery procedures, including transmyocardial laser revascularization, complex valve reconstruction, and minimally invasive coronary artery bypass graft surgery.  Dr. Jeevanandam is a pioneer in the field of mechanical circulatory assist devices. In October 2000, he was the first surgeon in the world to successfully implant the CardioVad, a revolutionary, permanent circulatory assist device that boosts heart function in patients with severe heart failure who are not candidates for transplant. He continues to be a recognized leader in the field of advanced heart failure and currently serves on the FDA Device Panel.  He is a world-renowned surgeon, having started high risk and cardiac assist programs in countries including China, India, as well as countries in the Middle East and South America.

Changqing Gao, MD
PLA General Hospital

Known as the "Father of Robotic Cardiac Surgery in Asia", Prof. Gao and his surgical team have utilized the da Vinci Surgical System to its maximum potential - performing all of the various types of cardiac surgery of which the system is capable since the first case success in 2007. Until date, about 900 cases of robotic cardiac surgery have all been successfully completed. Prof. Gao and his surgical team is dedicated to the continued contribution to the future research and development of the techniques of robotic cardiac surgery and to the training of robotic surgeons both in China and abroad which will improve surgical outcomes for the patients worldwide.  Dr. Gao’s professional interests include acquired heart disease, mitral and aortic valve repair/replacement, aneurysms of the thoracic aorta, and heart transplantation. He has a special interest in complex coronary artery bypass, off-pump coronary artery bypass, surgical treatment of left ventricular aneurysm, and minimally invasive robotic cardiac surgery.  Dr. Gao holds important positions in many academic societies. He is the Councilor of the Chinese Medical Association, Vice Presidents of the Chinese Society of Thoracic and Cardiovascular Surgery and the Chinese Association of Cardiovascular Surgeons, President of the Beijing Society of Cardiac Surgery, Executive Councilors of the Beijing Medical Association and the Asian Society for Cardiovascular and Thoracic Surgery (ASCVTS), Board Directors of the ISMICS and SRS, and Members of AATS, STS and EACTS.

Dr. Go Watanabe is the Chairman and Professor of Department of Surgery  at the Kanazawa University School of Medicine in Japan.  He also holds the position of visiting professor of Department of Cardiac Surgery at the International Univeristy of Health and Welfare in Japan. Dr. Watanabe has performed more than 3,000 cardiac surgeries. In recent years, he has pioneered beating-heart totally endoscopic coronary artery bypass (BH TECAB) and off-pump coronary artery bypass through small holes, and performed more of these procedures than any other surgeon in the world. He can also perform coronary bypass surgery with robotic assistance in using da Vinci system. Beyond coronary bypass surgery, he has refined many other minimally invasive approaches to cardiac and thoracic surgery. Dr. Watanabe has special expertise in the surgical treatment of heart valve disease, heart failure, arrhythmias, and congenital heart disease in adults. He has also performed heart valve plasty for valvular diseases through robotic minimally invasive procedures.  He is an active member of the Asian Society for Cardiovascular and Thoracic Surgery, Cardiothoracic Surgery Network,

International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) and the Japanese Association for Thoracic Surgery.

Go Watanabe, MD
University of Kanazawa
Wickii Vigneswaran, MD
Loyola University

Dr. Wickii Vigneswaran is an internationally recognized expert in the surgical management of diseases affecting the heart, lungs, pleura and mediastinum. He is a professor at the Loyola University Health System in Illinois, where he also serves as chief of thoracic surgery.

Vigneswaran previously was professor of surgery, associate chief of cardiac and thoracic surgery, as well as director of the Lung and Heart-Lung Transplantation Division at the University of Chicago Medical Center, which U.S. News & World Report ranked as No. 15 cancer treatment in the nation.  A pioneer in the fields of minimally invasive, robot- and video-assisted thoracic surgery, Vigneswaran treats patients with advanced malignant diseases like lung cancer and mesothelioma.  Dr. Vigneswaran strongly advocates multidisciplinary and team-based approaches to disease management.   He leads several medical organizations, including the International College of Surgeons and the American College of Chest Physicians. He is certified in cardiothoracic surgery and is a fellow of surgical and medical societies in Scotland, England, Canada and the United States. His fellowships include the Royal College of Surgeons and Physicians of Canada, the Royal College of Surgeons of Edinburgh, the American College of Surgeons, the American College of Chest Physicians and the Royal Society of Medicine.

Minoru Ono, MD, PhD
University of Tokyo

Dr. Minoru Ono is a physician at the University of Tokyo Hospital Department of Cardiovascular Surgery & Department of Cooperative Unit of Medicine and Engineering Research.  His areas of expertise and specialties include Adult Cardiac Surgery, Minimally Invasive Cardiac Surgery, Robotic Cardiac Surgery, Mitral Valve Plasty, Off-pump Coronary Artgery Bypass Surgery, Ventricular Assist Device and Heart Transplantation.  Dr. Ono's research interests include Surgical Treatment of End-stage Heart Failure (Ventricular assist device, Heart transplantation, Mitral complex plasty), Device Development for Minimally Invasive Surgery and Regenerative Medicine.  Dr. Ono is a member of many academic societies including, Japan Surgical Society (Council Member), Japanese Society for Thoracic Surgery (Council Member), Japanese Society for Cardiovascular Surgery (Council Member), Japanese Circulation Society (Council Member), Japanese College of Cardiology (Board Member), Japanese Society for Artificial Organs (Vice President), Japanese Transplantation Society (Council Member), Japanese Society for Computer Assisted Surgery (Board Member), International Society for Rotary Blod Pumps (Member of Board of Trustee), The Transplantation Society and theInternational Society for Heart and Lung Transplantation.

T. Sloane Guy, MD
Weill Cornell Hospital

Dr. T. Sloane Guy grew up in North Carolina and then attended college at Wake Forest University on an Army ROTC scholarship.  He was a walk-on varsity football player, graduating Magna Cum Laude with honors in 1989.  With help from the U.S. Army’s health professions scholarship program, Dr. Guy earned both an MBA in Healthcare Administration from the Wharton School of Business and his M.D. from the University of Pennsylvania School of Medicine in 1994.  At Walter Reed Army Medical Center, Dr. Guy completed his general surgery internship before becoming a general medical officer and commander of a U.S. Army family practice clinic in Germany for 2 years.  From there he returned to Penn where he completed his general surgery residency and cardiothoracic surgery research and clinical fellowships.  He was extremely well-trained at Penn in adult cardiac surgery, valve repair and replacement, complex aortic surgery, heart failure surgery, robotics and minimally invasive surgery, finishing formal training in 2004.  After formal training and over several years, he also completed a series of "mini-fellowships" in advanced cardiac surgical techniques. These include Washington Hospital Center in D.C. (advanced off-pump coronary artery surgery), California Pacific Medical Center & Sequoia Hospital in California (advanced minimally invasive cardiac surgery),  and at St. Joseph's Hospital in Atlanta, GA (Intracardiac/mitral valve robotics procedures and robotic coronary bypass surgery).

Qiang Zhao, MD
Shanghai Ruijin Hospital 

Dr. Quiang Zhao is the Vice President, Professor and Director of Cardiac Surgery at Ruijin Hospital Shanghai Jiaotong University School of Medicine. Dr. Zhao's academic background and training include:

Nantong Medical College (M.D. 1986)
Shanghai Medical University (Ph.D. 1991)
Shanghai Medical University (Assistant professor, 1993-1995)
Albert Starr Heart Academy Fellowship (1995-1998)
Zhongshan Hospital Fudan University (Professor, 1998-2009)
Ruijing Hospital Shanghai Jiaotong University School of Medicine (2009- )

Dr.  Zhao is an active member of the Society of Thoracic Surgeons, International Society of Minimally Invasive Cardiac Surgery and President of the Chinese Association of Coronary Surgery.   Dr. Zhao's clinical areas of interest and expertise include, Surgical Treatment for Heart Failure, Minimally Invasive and Robotic Heart Surgery, Adult Cardiac Surgery, Heart Valve Surgery, Gene and Cell Therapy in Cardiac Surgery and Coronary Bypass Grafting Surgery.

Douglas Boyd, MD
UC Davis Medical Center

Dr. Douglas Boyd is recognized for his pioneering work in cardiothoracic surgery and for his use of robotic-assisted surgical systems. He specializes in minimally invasive cardiac and robotic-assisted heart surgery. He completed the world?s first closed-chest, beating-heart coronary artery bypass surgery using a robotic system in 1999 and performed the first human extracellular matrix xenograft implant for cardiovascular repair several years later. Prior to his appointment as a professor of surgery at UC Davis Health System, Dr. Boyd served as chair of the Department of Cardiothoracic Surgery at the Cleveland Clinic in Florida. As the author of more than 50 peer-reviewed, journal articles, Dr. Boyd's research interests include cardiac tissue regeneration using extracellular matrix/stem cells, new techniques for robot-assisted minimally invasive coronary artery revascularization, valve surgery and telesurgery.  As principal investigator in numerous clinical research trials, Dr. Boyd's research has focused on invasive robotic surgery, image guided minimally invasive cardiothoracic surgery, minimally beating heart surgery, and improving patient safety in cardiac surgery.  Dr. Boyd has authored or co-authored book chapters in medical textbooks on robotic cardiac bypass surgery and computer-assisted interventions among many other heart-related topics and has published numerous abstracts on his specialty interest.  He is a graduate of Carleton University and obtained his medical degree the University of Ottawa.  

Dr. Jae-Won Lee graduated from Seoul National University with Ph.D Degree in 1991. He is the Chairman and Professor of the Department of Thoracic & Cardiovascular Surgery of Asan Medical Center, Chairman of Medical Insurance and Government Relations in Korean Society of T & CVS, Executive Director of Korean Society of T & CVS, Director of Korean Society of Transplantation, Director of Valvular Heart Disease Center of ASAN Heart Institute, Surgical Director of ASAN Heart Institute, and Elected Member of National Academy of Medicine of Korea in 2010, Member of American Association for Thoracic Surgery in 2011.

 

His major areas of expertise and interest include mitral repair, atrial fibrillation surgery, MICS and robotic surgery, Ross operation, less invasive aortic surgery, and heart transplantation.  

Jae-Won Lee, MD
Asan Medical Center

SSI SENIOR MANAGEMENT

Rajen Ghadiok, MD
President
 Asia-Pacific Operations

Dr. Ghadiok brings with him over three decades of rich professional experience in the Healthcare Sector. He has significant leadership experience at the senior management level in growing corporate healthcare organizations with a successful record in leading and managing programs including designing, implementation and monitoring with practical hands‐on experience in operations and policy initiatives.

With experience in the different facets of healthcare management, he understands the intricacies of delivery systems and the issues, challenges and opportunities that face emerging markets.

Prior to joining the SS Innovations, he has served at senior executive positions at Fortis Healthcare Limited, Nova Medical Centres, and at International Rehabilitation and Sports Medicine Private Limited. Some of the areas of focus in these organizations were, structuring, recruitment of senior fraternity, financial modeling for senior medical staff in their engagement with the organization and helping in raising finances for growth and development. 

Vishwa Srivastava
Supervisor, SSI
President, OMNI 3DHD

Vishwa Srivastava has been involved in the field of robotic assisted surgery since 2008.  He completed his premedical courses at Columbia University in New York City and is presently in the process of completing his medical degree.  In 2009, while working as the Director of Digital Media and Technology at St. Joseph's Hospital in Atlanta, Vishwa was the first person in the field to develop a high definition teaching website for robotic cardiac surgery.  The goal was to assist in cardiothoracic surgeons lessening their respective learning curves through didactic training modules as they transitioned from conventional approaches to minimally invasive robotic approaches. Soon after, he began his research in the concept of tele-mentoring in surgical procedures.  In 2011, while working as the VP of Marketing and Technology at the International Centre for Robotic Surgery in New Delhi, Vishwa led the development of the OMNI 3D Medical Visualization system.  The 2013-2014 clinical trials for the OMNI system were conducted at Shanghai Ruijin Hospital, Medanta Hospital in New Delhi, the University of Chicago, Temple University in Philadelphia and Lennox Hill Hospital in New York City. Vishwa presently serves as the President of OMNI 3D HD and is advancing the existing technological platform for availability in the global surgical endoscopic marketplace.

Anup Sethi
Group CFO

Mr. Anup Sethi comes with a multi-faceted experience of more than 25 years in the field of Corporate Finance, Corporate Planning and Strategy, Mergers and Acquisitions, Accounting, Compliances and International Operations.  He has worked in senior management roles in a variety of industries ranging from Manufacturing and Digital Technology to Healthcare with organisations of diverse sizes from start-ups to large multi location business houses both in India and abroad.  Mr. Sethi also had the opportunity to build and work with multi-cultural teams while working for organisations in South Africa, China and Nigeria. 

Mr. Sethi plays a key role in SSI Groups' Corporate Finance, Accounting and Compliances as well as actively participating in SSI's Strategic Initiatives.

Mr. Sethi is a Fellow Member of the Institute of Cost Accountants of India and an Associate Member of CPA, Australia.

SSI TECHNOLOGY PARTNERSHIPS

Energid Technologies develops advanced software and robotic systems for the aerospace, agriculture, manufacturing, transportation, defense, and medical industries. Energid’s Actin® software is a powerful control framework and operating system for commercial, industrial, and mission critical robots that is sold as a cross platform application and extensible software toolkit. Energid specializes in the control, simulation, and sensing of complex robotic systems.  Energid’s robotics software has applications in numerous fields, including factory automation, surgical operations, agricultural harvesting and processing, entertainment, space exploration, and more. Our robotics software is best-in-class, simplifying integration and shredding months or years of development projects.

 

Sentir Technologies designs, develops and licenses technology and systems for affordable, high performance, haptic interaction.  The Sentir Team has developed more 3D Haptic enabled systems than any other company in the world with over two decades of experience designing and developing cutting edge human computer interfaces that incorporate the sense of touch. The Sentir Team, led by industry pioneer Walt Aviles, has an unparalleled knowledge of the field.

 

The journey of a thousand miles begins with a small step. DesignTech Systems, India, commenced a humble beginning in the year 1998. Guided by the focused vision of the Managing Director, Vikas Khanvelkar and with the encouraging support of the partner and Director, Sachin Chougule, DesignTech Systems started spreading its wings. They began providing technological excellence in the domain of CAD / CAM / CAE & PLM, thereby bringing 2200+ customers under its ecosystem. Determination, dedication and discipline powered by innovation have helped DesignTech achieve success.  

 

Han’s Motor is a global supplier in direct drive technology, ranging from linear motors, torque motors, servo drives, robots to customized motors and other industrial automation Solutions.Founded in Shenzhen, China in 2005, Han’s Motor has rapidly grown to the leading company in its domestic market, fully equipped with over 400 dedicated people in R&D, production, supply chain, quality, sales, and support functions. Today, Han’s Motor successfully stands as one of the leading suppliers of innovative direct-drive products and solutions for industry customers.

 

 

Established in 1989, Heal Force Bio-Meditech Holdings Limited is a Chinese manufacturer of medical equipment, laboratory equipment, and healthcare equipment. With over two decades of experience in the field, we are able to provide a vast range of products, including our electrosurgical generator, anesthetic machine, patient monitor, biological safety cabinet, laboratory centrifuge, pulse oximeter, massager, and more. In addition, we can also offer customized solutions for clients' special requirements. Headquartered in Hong Kong, our company has grown steadily and now has many subsidiaries, like Heal Force Development Limited, Nison Instrument (Shanghai) Limited, Shanghai Lishen Scientific Equipment Company, Shenzhen Creative Industry Company, Shanghai Lonyee Company, to name a few. 

TECH SUN has been in business  for over 5 years , it specializes in machine tooling and manufacturing of customized parts and systems as well as building automation for customers manufacturing needs. Tech Sun has been helping SSI with the prototype components for its system.

OMNI 3D HD specializes in providing the latest technology to facilitate operating room work flows respective to the field of Minimally Invasive Surgery.  Minimally Invasive Surgery (MIS) has demonstrated, since its inception into current medical procedures, to be the most advantageous form of surgery that a patient can receive.  Within the field of MIS it has been shown that improved visual clarity and depth perception in the operating room leads to a more precise operation.  The OMNI 3D HD System allows the entire surgical team to be able to see endoscopic video on a 3D 4K High Definition monitor.  The OMNI 3D HD model is compatible with the current DaVinci Robotic System.  The 3D display allows appropriate depth perception, as seen by the operating surgeon through the robotic console

  • LinkedIn Social Icon
  • Twitter Social Icon
  • Google+ Social Icon

© 2017 by SS Innovations China Co., Ltd.